Published in Circ Res on October 01, 1963
Further observations on renal transplants in man from cadaveric donors. Br Med J (1966) 1.22
Angiotensin II in arterial and renal venous plasma and renal lymph in the dog. J Clin Invest (1971) 1.15
Diffusion of glucose, insulin, inulin, and Evans blue protein into thoracic duct lymph of man. J Clin Invest (1967) 1.10
The effect of altered sodium concentration in the distal nephron segments on renin release. J Clin Invest (1970) 0.85
TRANSFER OF EXPERIMENTAL RENAL HYPERTENSION AND VASCULAR DISEASE. Can Med Assoc J (1964) 0.81
Post-hydralazine renin release in the diagnosis of renovascular hypertension. Ann Surg (1969) 0.80
[The renin-angiotensin system: methodology and clinical importance]. Can Med Assoc J (1970) 0.75
Serotonin content of some mammalian tissues and urine and a method for its determination. Am J Physiol (1953) 3.48
Angiotensin. Physiol Rev (1961) 2.99
Electrophoretic and ultracentrifugal analysis of serum lipoproteins of normal, nephrotic and hypertensive persons. Circulation (1953) 2.97
A new, potent antihypertensive drug: preliminary study of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (guanethidine). J Am Med Assoc (1959) 2.83
Ultracentrifuge lipoprotein pattern of serum of normal, hypertensive and hypothyroid animals. Am J Physiol (1952) 2.69
The vascular action of natural serotonin, 5- and 7-hydroxytryptamine and tryptamine. J Pharmacol Exp Ther (1952) 2.63
The variable arterial pressure response to serotonin in laboratory animals and man. Circ Res (1953) 2.57
Urinary formaldehydogenic corticoids: normal values and observations in hypertension. J Lab Clin Med (1950) 2.33
Mechanisms, diagnosis and treatment of hypertension of renal vascular origin. Ann Intern Med (1959) 2.31
Cardiovascular actions of sodium nitroprusside in animals and hypertensive patients. Circulation (1955) 2.15
Significance of cryoprofibrin in fibrinogen-fibrin conversion. J Exp Med (1962) 2.15
Baroceptor function in chronic renal hypertension. Circ Res (1956) 2.12
Effect of triton on lipoprotein lipase of rat plasma. Am J Physiol (1957) 1.95
The effectiveness of long-term treatment of malignant hypertension. Circulation (1958) 1.90
Serotonin (5-hydroxytryptamine); the last four years. Physiol Rev (1958) 1.89
Serotonin (5-hydroxytryptamine). Physiol Rev (1954) 1.80
Angiotensinase with a high degree of specificity in plasma and red cells. Science (1963) 1.76
Ability of vasoconstrictor drugs to cause adrenal medullary discharge after "sensitization" by ganglion stimulating agents. Circ Res (1961) 1.75
Peripheral vasomotor effects of adrenaline and noradrenaline acting upon the isolated perfused central nervous system. Circulation (1951) 1.67
Atherosclerosis; an introduction. Circulation (1954) 1.67
Serum vasoconstrictor, serotonin; isolation and characterization. J Biol Chem (1948) 1.66
CONTROL OF RENIN SECRETION. Circ Res (1964) 1.60
A hormonal neurogenic vasopressor mechanism. AMA Arch Intern Med (1951) 1.59
Plasma lipids and proteins and their relationship to coronary disease among Navajo Indians. Circulation (1956) 1.59
Studies on the protective power of adrenal extract and steroids against bacterial toxins in adrenalectomized rats. Ann N Y Acad Sci (1949) 1.58
Serum lipid levels in normal persons; findings of a cooperative study of lipoproteins and atherosclerosis. Circulation (1957) 1.48
Induced hypercholesterolemia and atherogenesis. Circulation (1952) 1.43
Relationships among intravascular volume, total body sodium, arterial pressure, and vasomotor tone. Circ Res (1961) 1.42
Use of fat-modified foods for serum cholesterol reduction. JAMA (1963) 1.41
A mechanism of chlorothiazide-enhanced effectiveness of antihypertensive ganglioplegic drugs. Circulation (1959) 1.40
RENAL BAROCEPTOR CONTROL OF RENIN SECRETION. Science (1963) 1.39
The metabolism of serotonin (5-hydroxytryptamine). J Biol Chem (1959) 1.36
Augmentation of vasoactive substances by tetraethylammonium chloride. Circulation (1950) 1.36
Argentaffinoma as endocrine tumour. Lancet (1955) 1.35
The prolonged treatment of hypertension with guanethidine. JAMA (1961) 1.34
Accelerated hypertensive vascular disease from saline and renin in nephrectomized dogs. AMA Arch Pathol (1953) 1.28
Effects of bradykinin and angiotensin on smooth muscle. Ann N Y Acad Sci (1963) 1.26
Hypertension due to renal compression resulting from subcapsular hematoma. J Urol (1955) 1.25
Mecamylamine in treatment of hypertensive disease; observations on an unusual neuromuscular complication. J Am Med Assoc (1956) 1.25
New metabolites of serotonin in carcinoid urine. Science (1958) 1.25
Studies on the antigenicity of beta- and alpha-lipoproteins of human serum. J Exp Med (1958) 1.25
Antidiuresis and other renal responses to piperoxan in pheochromocytoma. Circulation (1956) 1.24
Serotonin metabolism in carcinoid syndrome with metastatic bronchial adenoma. J Am Med Assoc (1959) 1.24
The peripheral cardiovascular actions of guanethidine in dogs. J Pharmacol Exp Ther (1961) 1.23
Enhanced effectiveness of ganglion-blocking agents in hypertensive patients during administration of a saluretic agent (chlorothiazide). Lancet (1957) 1.23
A vasopressor lipid in incubated plasma. Am J Physiol (1960) 1.22
Holmes-Adie syndrome with progressive autonomic degeneration. Australas Ann Med (1961) 1.22
Pharmacologic aspects of synthetic angiotonin. Circ Res (1957) 1.21
Modification of vascular response to serotonin by drugs. Am J Physiol (1953) 1.20
Atherosclerosis and the fat content of the diet. Circulation (1957) 1.16
Experimental production of a syndrome resembling toxemia of pregnancy. J Lab Clin Med (1951) 1.16
Lithium poisoning from the use of salt substitutes. J Am Med Assoc (1949) 1.15
Further evaluation of hydralazine in treatment of hypertensive disease. AMA Arch Intern Med (1954) 1.14
Angiotensin II: its metabolic fate. Science (1962) 1.14
The local metabolic action of adrenaline on skeletal muscle in man. J Physiol (1961) 1.12
Synthesis and pharmacology of the octapeptide angiotonin. Science (1957) 1.12
The influence of respiratory gas mixtures on arterial pressure and vascular reactivity in normal and hypertensive dogs. Circulation (1951) 1.12
Blood pressure in the unanesthetized rat. II. Spontaneous variations and effect of heat. Circulation (1951) 1.12
Ability of serotonin and norepinephrine to mimic the central effects of reserpine on vasomotor activity. Circ Res (1960) 1.12
DISTRIBUTION AND METABOLIC FATE OF ANGIOTENSIN II AND VARIOUS DERIVATIVES. Can Med Assoc J (1964) 1.12
AN UNUSUAL SERUM LIPOPROTEIN-GLOBULIN COMPLEX IN A PATIENT WITH HYPERLIPEMIA. Am J Med (1965) 1.11
Mechanisms in the return of vascular tone following sympathectomy in man. Circ Res (1961) 1.10
Renal function in primary aldosteronism. J Clin Invest (1956) 1.10
Renal hypertension. N Engl J Med (1959) 1.10
Electrophoretic study of plasma proteins following hepatectomy in dogs. Am J Physiol (1949) 1.07
HEMODYNAMIC STUDIES IN NORMOTENSIVE AND RENAL HYPERTENSIVE CHRONIC SPINAL DOGS. Am J Physiol (1964) 1.07
The effect of venous occlusion on serum cholesterol and total protein concentration-a warning. Circulation (1962) 1.05
Nature of the hypotensive action of a thiophanium derivative (Ro 2-2222) in dogs. J Pharmacol Exp Ther (1952) 1.05
The circulation in forearm skin and muscle during adrenaline infusions. Aust J Exp Biol Med Sci (1962) 1.04
Cardiovascular action of 1,1-dimethyl-4-phenylpiperazinium iodide (DMPP); a ganglion stimulating agent useful in the diagnosis of pheochromocytoma. Am J Med (1953) 1.04
Treatment of the nephrotic syndrome with nitrogen mustard. J Lab Clin Med (1950) 1.02
Renal and vascular lesions elicited by renin in rats with desoxycorticosterone hypertension. AMA Arch Pathol (1952) 1.02
Effects of renin and thyroxine in rats treated with corticosteroids and in rats with regenerating adrenals. Endocrinology (1957) 1.01
RENAL BARORECEPTOR CONTROL OF ACUTE RENIN RELEASE IN NORMOTENSIVE, NEPHROGENIC AND NEUROGENIC HYPERTENSIVE DOGS. Circ Res (1964) 1.01
Serotonin or tenure for the pharmacologist. Circulation (1956) 1.00
Effects of serotonin antagonists in normal subjects and patients with carcinoid tumors. Circulation (1957) 0.99
Serotonin and its methylated derivatives in human urine. J Biol Chem (1955) 0.99
The chemoceptor stimulant action of serotonin in dogs. J Pharmacol Exp Ther (1956) 0.99
Treatment of essential and malignant hypertension. J Am Med Assoc (1951) 0.98
Arterial hypertension. Pa Med J (1952) 0.98
Triton hyperlipemia in dogs. II. Atheroscieross, diffuse lipidosis, and deletion of fat stores produced by prolonged administration of the non-tonic surface-active agent. J Exp Med (1961) 0.97
Current status of bretylium and guanethidine as antihypertensive drugs. Circulation (1960) 0.97
Controlled observations on the effect of low sodium dietotherapy in essential hypertension. Circulation (1951) 0.96
Cortisone and ACTH in essential hypertension; establishment of renal glycosuria. AMA Arch Intern Med (1951) 0.96
Effects of renin in rats treated with methylandrostenediol. Endocrinology (1955) 0.96
Hemodynamic effects of eledoisin, kallidin II, and bradykinin in unanesthetized dogs. Am J Physiol (1962) 0.96
Mechanism by which serotonin, norepinephrine and reserpine cause central vasomotor inhibition. Circ Res (1960) 0.96